Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-25-004564
Filing Date
2025-01-13
Accepted
2025-01-13 07:30:10
Documents
29
Period of Report
2025-01-13

Document Format Files

Seq Description Document Type Size
1 6-K investor_presentation_1.htm 6-K 24229
2 EX-99.1 imab-ex99_1.htm EX-99.1 37393
3 GRAPHIC imab-ex99_1s1.jpg GRAPHIC 190190
4 GRAPHIC imab-ex99_1s2.jpg GRAPHIC 984532
5 GRAPHIC imab-ex99_1s3.jpg GRAPHIC 271401
6 GRAPHIC imab-ex99_1s4.jpg GRAPHIC 397922
7 GRAPHIC imab-ex99_1s5.jpg GRAPHIC 319650
8 GRAPHIC imab-ex99_1s6.jpg GRAPHIC 488819
9 GRAPHIC imab-ex99_1s7.jpg GRAPHIC 440180
10 GRAPHIC imab-ex99_1s8.jpg GRAPHIC 367240
11 GRAPHIC imab-ex99_1s9.jpg GRAPHIC 459631
12 GRAPHIC imab-ex99_1s10.jpg GRAPHIC 389400
13 GRAPHIC imab-ex99_1s11.jpg GRAPHIC 313304
14 GRAPHIC imab-ex99_1s12.jpg GRAPHIC 293432
15 GRAPHIC imab-ex99_1s13.jpg GRAPHIC 275510
16 GRAPHIC imab-ex99_1s14.jpg GRAPHIC 259533
17 GRAPHIC imab-ex99_1s15.jpg GRAPHIC 350604
18 GRAPHIC imab-ex99_1s16.jpg GRAPHIC 431702
19 GRAPHIC imab-ex99_1s17.jpg GRAPHIC 304517
20 GRAPHIC imab-ex99_1s18.jpg GRAPHIC 312671
21 GRAPHIC imab-ex99_1s19.jpg GRAPHIC 385748
22 GRAPHIC imab-ex99_1s20.jpg GRAPHIC 251208
23 GRAPHIC imab-ex99_1s21.jpg GRAPHIC 342258
24 GRAPHIC imab-ex99_1s22.jpg GRAPHIC 298593
25 GRAPHIC imab-ex99_1s23.jpg GRAPHIC 423601
26 GRAPHIC imab-ex99_1s24.jpg GRAPHIC 387235
27 GRAPHIC imab-ex99_1s25.jpg GRAPHIC 359012
28 GRAPHIC imab-ex99_1s26.jpg GRAPHIC 390862
29 GRAPHIC imab-ex99_1s27.jpg GRAPHIC 211533
  Complete submission text file 0000950170-25-004564.txt   13694280
Mailing Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850
Business Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850 (301) 670 2800
I-Mab (Filer) CIK: 0001778016 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39173 | Film No.: 25524802
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)